ClinicalTrials.Veeva

Menu

Severe Septic Shock Complications

I

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Status

Unknown

Conditions

Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT03716895
SSS-500

Details and patient eligibility

About

Adults older than 18 years old, admitted to the ICU with a Severe Septic Shock, requiring Norepinephrine at more than 0.25mcg/kg/min, who have signed informed consent form, will be consecutively included, from december 2018 to december 2019.

The primary goal is to look for risk factors associated with an increased in lactate clearance

Secondary goals are the following:

  1. To look for risk factors associated with an increase risk of Hospital and ICU length of stay.
  2. To look for risk factors associated with an increase risk of Acute Kidney Injury.
  3. To look for risk factors associated with a decrease in days alive and free of Mechanical Ventilation, Vasopressors and Renal Replacement Therapy.
  4. To look for risk factors associated with a decrease in Ventilator-free days.
  5. To look for risk factors associated with a decrease in Vasopressor-free days.
  6. To look for risk factors associated with an increase risk of in-hospital mortality.
  7. To look for risk factors associated with an increase risk of Myocardial Infarction and myocardial injury.
  8. To look for risk factors associated with an increase risk of Acute Respiratory Distress Syndrome.
  9. To compare and validate different risk scores in our cohort.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults older than 18 years old admitted to ICU with Severe Septic Shock

Exclusion criteria

  • Rejecting participation by not signing informed consent form.

Trial contacts and locations

1

Loading...

Central trial contact

Marc Vives, PhD, DESA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems